Post by
Noteable on May 28, 2024 11:45am
Roche/Genentech head deal-maker moves on after 14 years
May 28, 2024 - James Sabry, global head at Roche Pharma Partnering, is moving on from the Swiss pharma giant.
He will be succeeded by Boris Zatra, Roche’s head of group business development, who will take on the title of head of corporate business development on July 1. He will report to Roche CEO Thomas Schinecker.
Zatra, presently Head of Group Business Development, will be appointed as the Head of Corporate Business Development. This new role will merge the functions of Pharma Partnering and Group Business Development, as stated in Roche’s Monday announcement. Zatra has been with Roche since 2012, starting his journey in Basel.
https://www.mmm-online.com/home/channel/people-moves/james-sabry-roche-global-head-of-partnering-retires/
Comment by
13X2413 on May 28, 2024 1:08pm
Hence the enormous interest in Onc. (Eye roll) I'm feeling better about the pick up in volume and stock price. (2nd eye roll)
Comment by
Peladawn on May 28, 2024 5:32pm
If you think there's no hope, then why don't you go away?......(middle finger outstretched)